Skip to search formSkip to main contentSkip to account menu

Ulocuplumab

An orally bioavailable monoclonal antibody against CXC Chemokine Receptor 4 (CXCR4) with potential antineoplastic activity. Ulocuplumab binds to the… 
National Institutes of Health

Search for papers about Ulocuplumab

Search papers